25/m mit erythematösen, verkrusteten, schmerzhaften Knoten im Bartbereich

Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505–520

von Eiff C, Becker K, Machka K et al (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 344:11–16

Sunderkötter C, Becker K, Eckmann C, Graninger W, Kujath P, Schöfer H (2019) 2k-Leitlinie Haut- und Weichgewebeinfektionen. Auszug aus der S2k-Leitlininie „Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen“. JDDG. (in Druck)

Becker K, Sunderkötter C (2012) Skin infections with MRSA. Epidemiology and clinical features. Hautarzt 63(5):371–380

Alsterholm M, Flytstrom I, Bergbrant I‑M, Faergemann J (2010) Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol 90:52–57

Ondusko DS et al (2018) Staphylococcus aureus. Pediatr Rev 39(6):287–298

Sunderkötter C, Becker K (2015) Frequent bacterial skin and soft tissue infections: diagnostic signs and treatment. J Dtsch Dermatol Ges 13(6):501–2461

Saeed K et al (2018) Hot topics in necrotising skin and soft tissue infections. Int J Antimicrob Agents 52(1):1–10

Shands KN et al (1980) Toxic-shock syndrome in menstruating women—association with tampon use and staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303:1436–1442

Schwarz H (2014) Staphylococcal scalded skin syndrome: diagnosis and management in children and adults. J Eur Acad Dermatol Venereol 28:1418. https://doi.org/10.1111/jdv.12541

Peacock SJ et al (2015) Mechanisms of methicillin resistance in staphylococcus aureus. Annu Rev Biochem 84:577–601

Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM et al (2001) Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358:207–208

Löffler B, Hussain M, Grundmeier M et al (2010) Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 6:e1000715

Gillet Y, Issartel B, Vanhems P et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753–759

Fogo A (2011) PVL positive Staphylococcus aureus skin infections. BMJ 343:d5343

Becker K et al (2014) Persistent and recurrent skin and soft tissue infections by Staphylococcus aureus. Impact of the small colony-variant (SCV) phenotype and of Panton-Valentine leukocidin (PVL)-positive S. aureus isolates. Hautarzt 65(1):15–25

Jappe U, Heuck D, Strommenger B et al (2008) Staphylococcus aureus in dermatology outpatients with special emphasis on community-associated methicillin-resistant strains. J Invest Dermatol 128:2655–2664

Sunderkötter C, Becker K (2014) Systemic therapy with antibiotics. Overview of important antibiotics in dermatology. Hautarzt 65(2):113–124

Dryden MS (2010) Complicated skin and soft tissue infection. J Antimicrob Chemother 65(Suppl 3):iii35–iii44

Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in medizinischen und pflegerischen Einrichtungen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jun;57(6):696–732.